EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Five-Year Quality of Life Outcome From a Randomized Controlled Trial Comparing Aortic Valve Replacement Through Upper Hemisternotomy and Full Median Sternotomy

Simon E van Putten iD, Idserd D G Klop, Pythia T Nieuwkerk, Badr Friguech, Geoffrey T L Kloppenburg, Robert J M Klautz, Bart P van Putte, Patrick Klein

European Journal of Cardio-Thoracic Surgery · 2026

DOI: 10.1093/ejcts/ezag077 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Simon E van Putten und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein 3435 CM, The Netherlands. Hauptthemen laut MEDLINE: Sternotomy, Quality of Life, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organization for Health Research and Development ZonMW, Edwards LifeSciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The impact of minimally invasive surgical aortic valve replacement (SAVR) on long-term quality of life (QoL) is uncertain. This randomized controlled trial compared QoL 5 years after SAVR through upper hemisternotomy (UHS) or full median sternotomy.

Methods

Patients undergoing SAVR were randomized to UHS or full median sternotomy. The primary outcome was postoperative cardiac-specific QoL during 5 years, assessed by the Kansas City Cardiomyopathy Questionnaire physical limitations domain. Secondary outcomes include survival, other QoL domains, and factors associated with declined QoL between 1 and 5 years.

Results

Surgical aortic valve replacement via UHS resulted in better QoL as indicated by more favourable physical limitation and total symptoms scores (estimated mean difference [95% confidence interval] −1.89 [−2.93 to −0.85; P-value ≤.001] and 2.96 [−4.71 to −1.22; P-value = .016], respectively). Quality of life improvement persisted for 5 years, despite a decline after 1 year postoperative. Age and valve size smaller than or equal to 21 were independent predictors of decline in physical functioning, while full median sternotomy independently predicted declined total symptoms score. Five-year survival was 91.9% and similar between approaches (P-value = .417).

Conclusions

Minimally invasive SAVR was associated with a modest but statistically significant improvement in cardiac-specific QoL over 5 years compared to median sternotomy, driven by earlier recovery, with comparable outcomes at 5 years. Full median sternotomy independently predicted decline in QoL demonstrated by decreased total symptom scores. Clinical registration number The Limited access Aortic valve Replacement trial is registered at ClinicalTrials.gov, number NCT04012060. Available via https://clinicaltrials.gov/study/NCT04012060.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SternotomyQuality of LifeHeart Valve Prosthesis ImplantationAortic ValveHumansFemaleMaleAgedTreatment OutcomeMiddle AgedMinimally Invasive Surgical Procedures

Stichwörter der Autor:innen

aortic valve replacementlong-term outcomesminimally invasivequality of lifesternotomysurgical aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein 3435 CM, The Netherlands.
  • Department of Cardiothoracic Surgery, Amsterdam University Medical Centre, Amsterdam 1105 AZ, The Netherlands.
  • Department of Medical Psychology, Amsterdam University Medical Centre, Amsterdam 1105 AZ, The Netherlands.
  • Amsterdam Public Health, Amsterdam University Medical Centre, Amsterdam 1105 AZ, The Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam 1105 AZ, The Netherlands.
  • Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden 2333 ZG, The Netherlands.

ORCID-Profile: Simon E van Putten

Förderung

  • Netherlands Organization for Health Research and Development ZonMW
  • Edwards LifeSciences

Zitieren

APA

van Putten, S. E., Klop, I. D. G., Nieuwkerk, P. T., Friguech, B., Kloppenburg, G. T. L., Klautz, R. J. M., van Putte, B. P., & Klein, P. (2026). Five-Year Quality of Life Outcome From a Randomized Controlled Trial Comparing Aortic Valve Replacement Through Upper Hemisternotomy and Full Median Sternotomy. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag077

Vancouver

van Putten SE, Klop IDG, Nieuwkerk PT, Friguech B, Kloppenburg GTL, Klautz RJM, et al. Five-Year Quality of Life Outcome From a Randomized Controlled Trial Comparing Aortic Valve Replacement Through Upper Hemisternotomy and Full Median Sternotomy. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag077

BibTeX
@article{vanPutten2026,
  author = {van Putten, Simon E and Klop, Idserd D G and Nieuwkerk, Pythia T and Friguech, Badr and Kloppenburg, Geoffrey T L and Klautz, Robert J M and van Putte, Bart P and Klein, Patrick},
  title = {Five-Year Quality of Life Outcome From a Randomized Controlled Trial Comparing Aortic Valve Replacement Through Upper Hemisternotomy and Full Median Sternotomy},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  doi = {10.1093/ejcts/ezag077}
}
Kostenlos starten →